Organ preservation in patients with rectal cancer
Ugeskrift for Læger · 02.11.2026 · 1-9
DOI: 10.61409/v03260208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ugeskrift for Læger, online erschienen am 02.11.2026. Verfasst von Kristoffer Ankær Brejndal und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Surgical resection has traditionally been the cornerstone of treatment for patients with rectal cancer but is associated with significant impacts on bowel-, bladder- and sexual function. Organ preservation involves the use of other treatment modalities, such as chemotherapy and radiotherapy, to treat the primary tumour and allow major surgery to be safely avoided without compromising oncological outcomes. Organ preservation is oncologically safe and can reduce but not eliminate the functional impact of treatment. However, patient selection remains a major challenge, as argued in this review.
Zitieren
APA
Brejndal, K. A., Nordholm, A. H., Schlesinger, N. H., Buskov, L., Qvortrup, C., Krarup, P., & Smith, H. G. (2026). Organ preservation in patients with rectal cancer. Ugeskrift for Læger, 1-9. https://doi.org/10.61409/v03260208
Vancouver
Brejndal KA, Nordholm AH, Schlesinger NH, Buskov L, Qvortrup C, Krarup P, et al. Organ preservation in patients with rectal cancer. Ugeskrift for Læger. 2026:1-9. doi:10.61409/v03260208
BibTeX
@article{Brejndal2026,
author = {Brejndal, Kristoffer Ankær and Nordholm, Andreas Hurup and Schlesinger, Nis H. and Buskov, Laura and Qvortrup, Camilla and Krarup, Peter-Martin and Smith, Henry G.},
title = {Organ preservation in patients with rectal cancer},
journal = {Ugeskrift for Læger},
year = {2026},
pages = {1--9},
doi = {10.61409/v03260208}
}
EUVIMED